Pemphigus Vulgaris vs. Bullous Pemphigoid
Comprehensive emergency evaluation and protocolized management of life-threatening autoimmune bullous dermatoses: Pemphigus Vulgaris (PV; anti-desmoglein 1 and 3 autoantibodies, intraepidermal acantholysis, fragile flaccid bullae, positive Nikolsky sign, prominent painful oral mucosal erosions preceding skin lesions, high mortality from cutaneous fluid loss and secondary bacterial sepsis) vs. Bullous Pemphigoid (BP; anti-hemidesmosome BP180/BP230 autoantibodies, subepidermal cleavage, firm tense bullae, negative Nikolsky sign, rare mucosal involvement, elderly demographics); emergency wound care (burn unit protocols); and high-dose corticosteroid/IVIG resuscitation.
Resuscitation Quick Actions • First 2 Minutes
Pemphigus: Flaccid & Nikolsky +
Flaccid blisters that rupture into painful denuded weeping erosions; POSITIVE Nikolsky sign (shearing of normal skin); ORAL MUCOSA INVOLVED
Pemphigoid: Tense & Nikolsky -
Tense, firm blisters on an erythematous base; NEGATIVE Nikolsky sign (skin does NOT shear); oral mucosa rarely involved; elderly
Pemphigus Resuscitation
Treat like a partial-thickness thermal burn: fluid/electrolyte replacement, sterile non-adherent dressings, avoid adhesive tapes
First-Line Pemphigus Steroids
Methylprednisolone 1 to 2 mg/kg IV daily (or oral Prednisone 1–1.5 mg/kg/day) immediately to halt ongoing desmoglein autoantibody damage
Bullous Pemphigoid First-Line
High-potency topical corticosteroid (Clobetasol propionate 0.05% cream 20–30 g/day applied to entire body) has lower mortality than oral steroids
Direct Immunofluorescence (DIF)
PV: intraepidermal 'fishnet/chicken-wire' IgG pattern; BP: linear IgG and C3 deposition along the subepidermal basement membrane zone
Bottom-Line Clinical Pearl
Autoimmune blistering dermatoses are divided by the anatomical depth of epidermal cleavage: (1) Pemphigus Vulgaris (PV) is an INTRAEPIDERMAL blister caused by IgG autoantibodies against DESMOGLEIN 1 and 3 (desmosomes connecting keratinocytes). Because the blister roof is paper-thin epidermis, bullae are FLACCID and rupture immediately, leaving raw, weeping, agonizingly painful erosions. NIKOLSKY SIGN IS POSITIVE (gentle tangential pressure on normal-appearing skin causes the epidermis to shear off). Severe oral mucosal erosions occur in > 90% of patients, often months before skin involvement. Mortality is high (septic shock, fluid/protein loss). Treat PV like a second-degree burn: IV fluid resuscitation, burn unit admission, and immediate high-dose IV Methylprednisolone (1–2 mg/kg/day). (2) Bullous Pemphigoid (BP) is a SUBEPIDERMAL blister caused by IgG against HEMIDESMOSOMES (BP180/BP230 anchoring the epidermis to the dermis). Because the entire full-thickness epidermis forms the blister roof, bullae are TENSE, FIRM, and RESISTANT TO RUPTURE. NIKOLSKY SIGN IS NEGATIVE; oral involvement is rare. Treat BP with high-potency topical steroids (Clobetasol 0.05%) or oral prednisone.
The structural integrity of the epidermis depends on two distinct adhesion complexes: (1) Desmosomes, which tether adjacent keratinocytes together within the epidermis, and (2) Hemidesmosomes, which anchor basal keratinocytes to the underlying dermis across the basement membrane zone.
| Autoimmune Bullous Disease | Molecular Antigen Target | Histopathologic Cleavage Level | Clinical Blister Morphology |
|---|---|---|---|
| Pemphigus Vulgaris (PV) | Desmoglein 3 (mucous membranes + deep epidermis) and Desmoglein 1 (superficial skin) | Intraepidermal Acantholysis: loss of cell-cell adhesion directly above the basal layer (suprabasilar split), leaving a single layer of basal cells attached to basement membrane ('tombstone appearance'). | Flaccid, fragile, thin-walled bullae that rupture with minimal friction, leaving agonizing, denuded, bleeding, non-healing erosions. Nikolsky Sign is POSITIVE. |
| Bullous Pemphigoid (BP) | Hemidesmosomal antigens: BP180 (collagen XVII) and BP230 (dystonin) in the basement membrane | Subepidermal Split: detachment of the entire full-thickness epidermis from the underlying papillary dermis with intense eosinophilic infiltrate in the blister cavity. | Tense, firm, dome-shaped bullae that persist for days without rupturing, arising on normal or urticarial erythematous skin. Nikolsky Sign is NEGATIVE. |
| Diagnostic Domain | Pemphigus Vulgaris (PV) | Bullous Pemphigoid (BP) |
|---|---|---|
| Typical Patient Age | Middle-aged adults (40 to 60 years); Mediterranean or Jewish descent | Elderly patients (> 70 to 80 years); associated with stroke, dementia, Parkinson's |
| Mucosal Involvement | PRESENT IN > 90% OF PATIENTS; painful, intractable oral, pharyngeal, and genital erosions that precede cutaneous blisters by months; severe dysphagia/weight loss | RARE (< 10–20%); oral lesions, if present, are mild and transient |
| The Nikolsky Sign | POSITIVE: Firm sliding tangential pressure of a finger over normal-appearing skin causes the epidermis to blister or slough off | NEGATIVE: Tangential pressure does not dislodge the epidermis |
| Direct Immunofluorescence | 'Fishnet/Chicken-wire' pattern: intraepidermal intercellular IgG and C3 deposition outlining individual keratinocyte cell borders | Linear continuous pattern: uniform ribbon of IgG and C3 deposited along the subepidermal basement membrane zone |
| Morbidity & Mortality | High Mortality (5–10%) without treatment; identical to a thermal burn (fluid loss, hypothermia, Staphylococcus aureus or Pseudomonas septic shock) | Low mortality; primary risks are iatrogenic adverse effects of systemic steroid therapy |
Test Your Pemphigus Vulgaris vs. Bullous Pemphigoid Clinical Acumen
Directly launch an active-recall practice block from our 8,400+ validated COMLEX Level 1, 2-CE & 3 board question bank with complete explanations.
Related Emergency Protocols & Differentials
Smoke Inhalation & Burn Resuscitation
Fluid replacement and wound care in cutaneous denudation.
Open Protocol Related EM ProtocolSoft Tissue & Necrotizing Infections
Secondary bacterial cellulitis and septic shock.
Open Protocol Related EM ProtocolUrticaria, Severe Erythemas & Drug Exanthems
SJS/TEN vs autoimmune blistering diseases.
Open Protocol